Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Vaccines

Free Subscription 14.06.2021 1 AIDS 8 BMJ 6 Clin Infect Dis 1 Clin Microbiol Rev 1 Indian Pediatr 4 J Infect 1 J Infect Dis 3 J Virol 7 JAMA 7 Lancet 4 MMWR Morb Mortal Wkly Rep 12 N Engl J Med 5 Nat Med 3 Pediatr Infect Dis J 3 Pediatrics 1 PLoS Med 5 PLoS One 4 Proc Natl Acad Sci U S A 2 Science 38 Vaccine 1 Virology 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. NDUATI EW, Gorman MJ, Sein Y, Hermanus T, et al
   Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccination.
   AIDS. 2021 Jun 10. pii: 00002030-900000000-96374.
   PubMed         Abstract available
   
   

   
   BMJ

2. KRISHTEL P, Malpani R
   Suspend intellectual property rights for covid-19 vaccines.
   BMJ. 2021;373:n1344.
   PubMed        
   
   
3. SHEPHERD A
   Protesters call for UK to back covid vaccine waiver.
   BMJ. 2021;373:n1388.
   PubMed        
   
   
4. BLOCK J
   US college covid-19 vaccine mandates don't consider immunity or pregnancy, and may run foul of the law.
   BMJ. 2021;373:n1397.
   PubMed        
   
   
5. MAHASE E
   Covid-19: UK has highest vaccine confidence and Japan and South Korea the lowest, survey finds.
   BMJ. 2021;373:n1439.
   PubMed        
   
   
6. MAHASE E
   Covid-19: Freedom won't last if UK doesn't share excess vaccine doses, aid agencies warn.
   BMJ. 2021;373:n1444.
   PubMed        
   
   
7. MAHASE E
   Childhood vaccination: Access problems in UK began way before covid-19.
   BMJ. 2021;373:n1436.
   PubMed        
   
   
8. LLOYD-SHERLOCK P, Kandiyil NM, McKee M, Perianayagam A, et al
   Pandemic lessons from India: inappropriate prioritisation for vaccination.
   BMJ. 2021;373:n1464.
   PubMed        
   
   
9. WISE J
   Covid-19: AstraZeneca vaccine linked with small risk of ITP, real world data show.
   BMJ. 2021;373:n1489.
   PubMed        
   
   

   
   Clin Infect Dis

10. MAROT S, Malet I, Leducq V, Abdi B, et al
    Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers.
    Clin Infect Dis. 2021 May 29. pii: 6288468. doi: 10.1093.
    PubMed         Abstract available
    
    
11. YEH HF
    The potential declining efficacy of the ChAdOx1 nCoV-19 vaccine(AZD1222) on inoculators with NSAIDs intake.
    Clin Infect Dis. 2021 Jun 3. pii: 6291428. doi: 10.1093.
    PubMed        
    
    
12. KAHN R, Holmdahl I, Reddy S, Jernigan J, et al
    Mathematical modeling to inform vaccination strategies and testing approaches for COVID-19 in nursing homes.
    Clin Infect Dis. 2021 Jun 4. pii: 6292250. doi: 10.1093.
    PubMed         Abstract available
    
    
13. JACOBSON MA, Zakaria A, Maung Z, Hart C, et al
    Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 SARS-CoV2 Vaccine (Moderna) in a Cohort of Hospital Employees.
    Clin Infect Dis. 2021 Jun 4. pii: 6291929. doi: 10.1093.
    PubMed         Abstract available
    
    
14. MWENDA JM, Hallowell BD, Parashar U, Shaba K, et al
    Impact of rotavirus vaccine introduction on rotavirus hospitalizations among children under 5 years of age - World Health Organization African Region, 2008-2018.
    Clin Infect Dis. 2021 Jun 5. pii: 6293961. doi: 10.1093.
    PubMed         Abstract available
    
    
15. VANKER A, McGeer A, O'Byrne G, Snyder ECR, et al
    Adverse Outcomes Associated with SARS-CoV-2 variant B.1.351 Infection in Vaccinated Residents of a Long Term Care Home, Ontario, Canada.
    Clin Infect Dis. 2021 Jun 6. pii: 6294072. doi: 10.1093.
    PubMed        
    
    

    
    Clin Microbiol Rev

16. SLACK MPE, Cripps AW, Grimwood K, Mackenzie GA, et al
    Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use.
    Clin Microbiol Rev. 2021 Jun 2:e0002821. doi: 10.1128/CMR.00028.
    PubMed         Abstract available
    
    

    
    Indian Pediatr

17. DHARMAPALAN D, John TJ
    COVID-19 Eradication for Vaccine Equity in Low Income Countries.
    Indian Pediatr. 2021 Jun 10. pii: S097475591600340.
    PubMed         Abstract available
    
    

    
    J Infect

18. BUTT AA, Khan T, Yan P, Shaikh OS, et al
    Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination.
    J Infect. 2021 May 28. pii: S0163-4453(21)00263.
    PubMed        
    
    
19. PEZZATI L, Giacomelli A, Mileto D, Conti F, et al
    Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: a cross-sectional study.: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine.
    J Infect. 2021 May 29. pii: S0163-4453(21)00271.
    PubMed        
    
    
20. RAW RK, Kelly C, Rees J, Wroe C, et al
    Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination.
    J Infect. 2021 May 29. pii: S0163-4453(21)00277.
    PubMed        
    
    
21. AKPOLAT T, Uzun O
    REDUCED MORTALITY RATE AFTER CORONAVAC VACCINE AMONG HEALTHCARE WORKERS.
    J Infect. 2021 Jun 8. pii: S0163-4453(21)00285.
    PubMed        
    
    

    
    J Infect Dis

22. MARAVELIA P, Frelin L, Ni Y, Perez NC, et al
    Blocking entry of hepatitis B and D viruses to hepatocytes as a novel immunotherapy for treating chronic infections.
    J Infect Dis. 2020 Jan 29. pii: 5717223. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

23. QIN Y, Tu K, Teng Q, Feng D, et al
    Identification of novel T-cell epitopes on infectious bronchitis virus N protein and development of a multi-epitope vaccine.
    J Virol. 2021 Jun 9:JVI0066721. doi: 10.1128/JVI.00667.
    PubMed         Abstract available
    
    
24. QIN K, Boppana S, Carlson JM, Fiore-Gartland A, et al
    Elevated HIV infection of CD4 T cells in MRKAd5 vaccine recipients due to CD8 T cells targeting of adapted epitopes.
    J Virol. 2021 Jun 2:JVI0016021. doi: 10.1128/JVI.00160.
    PubMed         Abstract available
    
    
25. NELSON SA, Dileepan T, Rasley A, Jenkins MK, et al
    Intranasal nanoparticle vaccination elicits a persistent, polyfunctional CD4 T cell response in the murine lung specific for a highly conserved influenza antigen that are sufficient to mediate protection from influenza virus challenge.
    J Virol. 2021 Jun 2:JVI0084121. doi: 10.1128/JVI.00841.
    PubMed         Abstract available
    
    

    
    JAMA

26. WOOD S, Schulman K
    When Vaccine Apathy, Not Hesitancy, Drives Vaccine Disinterest.
    JAMA. 2021 Jun 2. pii: 2780792. doi: 10.1001/jama.2021.7707.
    PubMed        
    
    
27. RYAN L
    Vaccinated but Not Protected-Living Immunocompromised During the Pandemic.
    JAMA. 2021 Jun 7. pii: 2781012. doi: 10.1001/jama.2021.9321.
    PubMed        
    
    
28. GOSTIN LO, Shaw J, Salmon DA
    Mandatory SARS-CoV-2 Vaccinations in K-12 Schools, Colleges/Universities, and Businesses.
    JAMA. 2021 Jun 7. pii: 2781010. doi: 10.1001/jama.2021.9342.
    PubMed        
    
    
29. TALBOT TR
    COVID-19 Vaccination of Health Care Personnel as a Condition of Employment: A Logical Addition to Institutional Safety Programs.
    JAMA. 2021 Jun 7. pii: 2781011. doi: 10.1001/jama.2021.8901.
    PubMed        
    
    
30. MEHRABADI A, Dodds L, MacDonald NE, Top KA, et al
    Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes.
    JAMA. 2021;325:2285-2293.
    PubMed         Abstract available
    
    
31. AZZIZ-BAUMGARTNER E, Grohskopf L, Patel M
    Realizing the Potential of Maternal Influenza Vaccination.
    JAMA. 2021;325:2257-2259.
    PubMed        
    
    
32. BERTOLLINI R, Chemaitelly H, Yassine HM, Al-Thani MH, et al
    Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar.
    JAMA. 2021 Jun 9. pii: 2781112. doi: 10.1001/jama.2021.9970.
    PubMed        
    
    

    
    Lancet

33. MAKONI M
    Africa's need for more COVID-19 clinical trials.
    Lancet. 2021;397:2037.
    PubMed        
    
    
34. FORMAN R, Jit M, Mossialos E
    Divergent vaccination policies could fuel mistrust and hesitancy.
    Lancet. 2021 Jun 1. pii: S0140-6736(21)01106.
    PubMed        
    
    
35. KOSAKA M, Hashimoto T, Ozaki A, Tanimoto T, et al
    Delayed COVID-19 vaccine roll-out in Japan.
    Lancet. 2021 Jun 2. pii: S0140-6736(21)01220.
    PubMed        
    
    
36. NNAJI CA, Ndwandwe D, Lesosky M, Mahomed H, et al
    Tackling missed opportunities for vaccination in a new era of immunisation.
    Lancet. 2021 Jun 2. pii: S0140-6736(21)01226.
    PubMed        
    
    
37. KUMAR A, Bernasconi V, Manak M, de Almeida Aranha AP, et al
    The CEPI centralised laboratory network: supporting COVID-19 vaccine development.
    Lancet. 2021;397:2148-2149.
    PubMed        
    
    
38. WALL EC, Wu M, Harvey R, Kelly G, et al
    Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
    Lancet. 2021 Jun 3. pii: S0140-6736(21)01290.
    PubMed        
    
    
39. BOLLYKY TJ, Murray CJL, Reiner RC Jr
    Epidemiology, not geopolitics, should guide COVID-19 vaccine donations.
    Lancet. 2021 Jun 8. pii: S0140-6736(21)01323.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

40. BARRY V, Dasgupta S, Weller DL, Kriss JL, et al
    Patterns in COVID-19 Vaccination Coverage, by Social Vulnerability and Urbanicity - United States, December 14, 2020-May 1, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:818-824.
    PubMed         Abstract available
    
    
41. O'CONNOR P, Yankovic D, Zimmerman L, Ben Mamou M, et al
    Progress Toward Rubella Elimination - World Health Organization European Region, 2005-2019.
    MMWR Morb Mortal Wkly Rep. 2021;70:833-839.
    PubMed         Abstract available
    
    
42. PATEL MURTHY B, Zell E, Kirtland K, Jones-Jack N, et al
    Impact of the COVID-19 Pandemic on Administration of Selected Routine Childhood and Adolescent Vaccinations - 10 U.S. Jurisdictions, March-September 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:840-845.
    PubMed         Abstract available
    
    
43. CHRISTIE A, Henley SJ, Mattocks L, Fernando R, et al
    Decreases in COVID-19 Cases, Emergency Department Visits, Hospital Admissions, and Deaths Among Older Adults Following the Introduction of COVID-19 Vaccine - United States, September 6, 2020-May 1, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:858-864.
    PubMed         Abstract available
    
    

    
    N Engl J Med

44. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Protecting the Immunosuppressed against Covid-19.
    N Engl J Med. 2021;384:e88.
    PubMed        
    
    
45. TAKUVA S, Takalani A, Garrett N, Goga A, et al
    Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study.
    N Engl J Med. 2021 Jun 2. doi: 10.1056/NEJMc2107920.
    PubMed        
    
    
46. NIXON DF, Ndhlovu LC
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    PubMed        
    
    
47. RANA K, Mohindra R, Pinnaka L
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    PubMed        
    
    
48. BLACHERE NE, Hacisuleyman E, Darnell RB
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants. Reply.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    PubMed        
    
    
49. TAPIA MD, Sow SO, Naficy A, Diallo F, et al
    Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers.
    N Engl J Med. 2021;384:2115-2123.
    PubMed         Abstract available
    
    
50. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccinating Children.
    N Engl J Med. 2021;384:e103.
    PubMed        
    
    
51. HEININGER U
    Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
    N Engl J Med. 2021 Jun 9. pii: 10.1056/NEJMc2107809.
    PubMed        
    
    
52. VANDEBOSCH A, Sadoff J, Douoguih M
    Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. Reply.
    N Engl J Med. 2021 Jun 9. pii: 10.1056/NEJMc2107809.
    PubMed        
    
    
53. RUBIN EJ, Baden LR, Longo DL, Morrissey S, et al
    Audio Interview: Treating Complications of Covid Vaccination.
    N Engl J Med. 2021;384:e107.
    PubMed        
    
    
54. BOURGUIGNON A, Arnold DM, Warkentin TE, Smith JW, et al
    Adjunct Immune Globulin for Vaccine-Induced Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMoa2107051.
    PubMed         Abstract available
    
    
55. 
    SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med. 2021;384:e92.
    PubMed        
    
    

    
    Nat Med

56. MAY M
    After COVID-19 successes, researchers push to develop mRNA vaccines for other diseases.
    Nat Med. 2021 May 31. pii: 10.1038/s41591-021-01393.
    PubMed        
    
    
57. SIMPSON CR, Shi T, Vasileiou E, Katikireddi SV, et al
    First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.
    Nat Med. 2021 Jun 9. pii: 10.1038/s41591-021-01408.
    PubMed         Abstract available
    
    
58. PISHKO AM, Bussel JB, Cines DB
    COVID-19 vaccination and immune thrombocytopenia.
    Nat Med. 2021 Jun 9. pii: 10.1038/s41591-021-01419.
    PubMed        
    
    
59. PRITCHARD E, Matthews PC, Stoesser N, Eyre DW, et al
    Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom.
    Nat Med. 2021 Jun 9. pii: 10.1038/s41591-021-01410.
    PubMed         Abstract available
    
    
60. MILMAN O, Yelin I, Aharony N, Katz R, et al
    Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals.
    Nat Med. 2021 Jun 10. pii: 10.1038/s41591-021-01407.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

61. BICKEL S, Harris C, Huxol H, Morton R, et al
    COVID-19 Vaccination Outcomes at a Pediatric Long-Term Care Facility.
    Pediatr Infect Dis J. 2021;40:e281-e283.
    PubMed        
    
    
62. SNAPIRI O, Rosenberg Danziger C, Shirman N, Weissbach A, et al
    Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine.
    Pediatr Infect Dis J. 2021 Jun 2. pii: 00006454-900000000-95800.
    PubMed         Abstract available
    
    
63. CLARK DR, Omer SB, Tapia MD, Nunes MC, et al
    Influenza or Meningococcal Immunization During Pregnancy and Mortality in Women and Infants: A Pooled Analysis of Randomized Controlled Trials.
    Pediatr Infect Dis J. 2020 May 1. doi: 10.1097/INF.0000000000002629.
    PubMed         Abstract available
    
    

    
    Pediatrics

64. BREWER NT, Gilkey MB, Thompson P
    RE: Progress in HPV Vaccine Hesitancy.
    Pediatrics. 2021;147.
    PubMed        
    
    
65. O'LEARY ST, Maldonado YA
    Myocarditis after SARS-CoV-2 Vaccination: True, True, and...Related?
    Pediatrics. 2021 Jun 4. pii: peds.2021-052644. doi: 10.1542/peds.2021-052644.
    PubMed        
    
    
66. MARSHALL M, Ferguson ID, Lewis P, Jaggi P, et al
    Symptomatic Acute Myocarditis in Seven Adolescents Following Pfizer-BioNTech COVID-19 Vaccination.
    Pediatrics. 2021 Jun 4. pii: peds.2021-052478. doi: 10.1542/peds.2021-052478.
    PubMed        
    
    

    
    PLoS Med

67. GRAY P, Kann H, Pimenoff VN, Eriksson T, et al
    Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial.
    PLoS Med. 2021;18:e1003588.
    PubMed         Abstract available
    
    

    
    PLoS One

68. KHOU C, Diaz-Salinas MA, da Costa A, Prehaud C, et al
    Comparative analysis of neuroinvasion by Japanese encephalitis virulent and vaccine viral strains in an in vitro model of human blood-brain barrier.
    PLoS One. 2021;16:e0252595.
    PubMed         Abstract available
    
    
69. NAKPHOOK S, Patumanond J, Shrestha M, Prasert K, et al
    Antibody responses induced by trivalent inactivated influenza vaccine among pregnant and non-pregnant women in Thailand: A matched cohort study.
    PLoS One. 2021;16:e0253028.
    PubMed         Abstract available
    
    
70. KAHANA D, Yamin D
    Accounting for the spread of vaccination behavior to optimize influenza vaccination programs.
    PLoS One. 2021;16:e0252510.
    PubMed         Abstract available
    
    
71. DUTTA S, Kumar A, Dutta M, Walsh C, et al
    Tracking COVID-19 vaccine hesitancy and logistical challenges: A machine learning approach.
    PLoS One. 2021;16:e0252332.
    PubMed         Abstract available
    
    
72. WOLDU HG, Zalwango S, Martinez L, Castellanos ME, et al
    Defining an intermediate category of tuberculin skin test: A mixture model analysis of two high-risk populations from Kampala, Uganda.
    PLoS One. 2021;16:e0245328.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

73. SIA ZR, He X, Zhang A, Ang JC, et al
    A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    
74. SCHMELZ K, Bowles S
    Overcoming COVID-19 vaccination resistance when alternative policies affect the dynamics of conformism, social norms, and crowding out.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    
75. SATO-KANEKO F, Yao S, Lao FS, Nan J, et al
    Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    
76. MCCARTHY KR, Von Holle TA, Sutherland LL, Oguin TH 3rd, et al
    Differential immune imprinting by influenza virus vaccination and infection in nonhuman primates.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    

    
    Science

77. COHEN J
    'Landmark' African vaccine trial faces impasse.
    Science. 2021;372:1135-1136.
    PubMed        
    
    
78. VOGEL G
    Mixing vaccines may boost immune responses.
    Science. 2021;372:1138.
    PubMed        
    
    

    
    Vaccine

79. LILES E, Irving SA, Dandamudi P, Belongia EA, et al
    Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination.
    Vaccine. 2021;39:3614-3620.
    PubMed         Abstract available
    
    
80. VANHEMS P
    A breath of humanity in the era of Covid-19 vaccine.
    Vaccine. 2021 May 24. pii: S0264-410X(21)00638.
    PubMed        
    
    
81. CHU H, Ko LK, Ibrahim A, Bille Mohamed F, et al
    The impact of an educational forum intervention on East African mothers' HPV vaccine-related knowledge, attitudes, and intentions to vaccinate their adolescent children.
    Vaccine. 2021 May 27. pii: S0264-410X(21)00593.
    PubMed         Abstract available
    
    
82. AIZAWA Y, Katsuta T, Sakiyama H, Tanaka-Taya K, et al
    Changes in childhood vaccination during the coronavirus disease 2019 pandemic in Japan.
    Vaccine. 2021 May 21. pii: S0264-410X(21)00636.
    PubMed         Abstract available
    
    
83. WAGNER NM, Dempsey AF, Narwaney KJ, Gleason KS, et al
    Addressing logistical barriers to childhood vaccination using an automated reminder system and online resource intervention: A randomized controlled trial.
    Vaccine. 2021 May 28. pii: S0264-410X(21)00639.
    PubMed         Abstract available
    
    
84. FENG Y, Yao T, Chang Y, Gao L, et al
    Immunogenicity and persistence of high-dose recombinant hepatitis B vaccine in adults infected with human immunodeficiency virus in China: A randomized, double-blind, parallel controlled trial.
    Vaccine. 2021;39:3582-3589.
    PubMed         Abstract available
    
    
85. VUJOVICH-DUNN C, Kaufman J, King C, Skinner SR, et al
    A systematic review and meta-analysis of effectiveness of decision aids for vaccination decision-making.
    Vaccine. 2021 May 26. pii: S0264-410X(21)00583.
    PubMed         Abstract available
    
    
86. VAILLANT L, Oster P, McMillan B, Velin D, et al
    Gastric eosinophils are detrimental for Helicobacter pylori vaccine efficacy.
    Vaccine. 2021;39:3590-3601.
    PubMed         Abstract available
    
    
87. GIDENGIL C, Goetz MB, Newberry S, Maglione M, et al
    Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis.
    Vaccine. 2021 May 23. pii: S0264-410X(21)00385.
    PubMed         Abstract available
    
    
88. SATTLER C, Hoffmann P, Herzberg PY, Weber D, et al
    Primary vaccination in adult patients after allogeneic hematopoietic stem cell transplantation - A single center retrospective efficacy analysis.
    Vaccine. 2021 May 25. pii: S0264-410X(21)00511.
    PubMed         Abstract available
    
    
89. MCFADDEN K, Heywood A, Dyda A, Kaufman J, et al
    Minimising missed opportunities to promote and deliver immunization services to middle and older age adults: Can hospital-based programs be a solution?
    Vaccine. 2021;39:3467-3472.
    PubMed         Abstract available
    
    
90. JETHWA H, Wong R, Abraham S
    Covid-19 vaccine trials: Ethnic diversity and immunogenicity.
    Vaccine. 2021;39:3541-3543.
    PubMed        
    
    
91. WANG Y, Zhang Y, Wu H, Huang L, et al
    Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: A randomized, double-blind, active-controlled phase 1 clinical trial.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00665.
    PubMed         Abstract available
    
    
92. MCGUINNESS D, Kaufhold RM, McHugh PM, Winters MA, et al
    Immunogenicity of PCV24, an expanded pneumococcal conjugate vaccine, in adult monkeys and protection in mice.
    Vaccine. 2021 May 29. pii: S0264-410X(21)00549.
    PubMed         Abstract available
    
    
93. GREWAL R, Deeks SL, Hart TA, Cox J, et al
    Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019.
    Vaccine. 2021 May 29. pii: S0264-410X(21)00603.
    PubMed         Abstract available
    
    
94. LEWIS NS, Banyard AC, Essen S, Whittard E, et al
    Antigenic evolution of contemporary clade 2.3.4.4 HPAI H5 influenza A viruses and impact on vaccine use for mitigation and control.
    Vaccine. 2021 May 29. pii: S0264-410X(21)00655.
    PubMed         Abstract available
    
    
95. STUURMAN AL, Biccler J, Carmona A, Descamps A, et al
    Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe - Results from the DRIVE EU study platform.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00654.
    PubMed         Abstract available
    
    
96. CHANDRA D, Vipin B
    On the vaccine supply chain coordination under subsidy contract.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00676.
    PubMed         Abstract available
    
    
97. ABU MOUCH S, Roguin A, Hellou E, Ishai A, et al
    Myocarditis following COVID-19 mRNA vaccination.
    Vaccine. 2021 May 28. pii: S0264-410X(21)00682.
    PubMed         Abstract available
    
    
98. ITO N, Okamoto T, Sasaki M, Miyamoto S, et al
    Safety enhancement of a genetically modified live rabies vaccine strain by introducing an attenuating Leu residue at position 333 in the glycoprotein.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00553.
    PubMed         Abstract available
    
    
99. BARDENHEIER BH, Gravenstein S, Blackman C, Gutman R, et al
    Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents.
    Vaccine. 2021 May 28. pii: S0264-410X(21)00683.
    PubMed         Abstract available
    
    
100. WOLFE LS, Smedley JG 3rd, Bubna N, Hussain A, et al
     Development of a platform-based approach for the clinical production of HIV gp120 envelope glycoprotein vaccine candidates.
     Vaccine. 2021 Jun 4. pii: S0264-410X(21)00668.
     PubMed         Abstract available
     
     
101. KARAFILLAKIS E, Francis MR, Paterson P, Larson HJ, et al
     Trust, emotions and risks: Pregnant women's perceptions, confidence and decision-making practices around maternal vaccination in France.
     Vaccine. 2021 Jun 4. pii: S0264-410X(21)00704.
     PubMed         Abstract available
     
     
102. NOGUERA M, Vela A, Kraft C, Chevalier M, et al
     Effects of three commercial vaccines against porcine parvovirus 1 in pregnant gilts.
     Vaccine. 2021 Jun 4. pii: S0264-410X(21)00614.
     PubMed         Abstract available
     
     
103. CHUA JV, Davis C, Husson JS, Nelson A, et al
     Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial.
     Vaccine. 2021 Jun 4. pii: S0264-410X(21)00685.
     PubMed         Abstract available
     
     
104. UWINS C, Cyriac S, Bhandoria G
     HPV vaccine: Expanding indications and global disparity.
     Vaccine. 2021 Jun 3. pii: S0264-410X(21)00677.
     PubMed        
     
     
105. GATES A, Rahman S, Sim S, Pillay J, et al
     Health inequities related to vaccination: An evidence map of potentially influential factors and systematic review of interventions.
     Vaccine. 2021 Jun 3. pii: S0264-410X(21)00640.
     PubMed         Abstract available
     
     
106. GURWITZ D
     COVID-19 vaccine hesitancy: Lessons from Israel.
     Vaccine. 2021 May 27. pii: S0264-410X(21)00680.
     PubMed        
     
     
107. BREWER NT, Mitchell CG, Alton Dailey S, Hora L, et al
     HPV vaccine communication training in healthcare systems: Evaluating a train-the-trainer model.
     Vaccine. 2021 May 30. pii: S0264-410X(21)00610.
     PubMed         Abstract available
     
     
108. GUBERNOT D, Jazwa A, Niu M, Baumblatt J, et al
     U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines.
     Vaccine. 2021 May 14. pii: S0264-410X(21)00578.
     PubMed         Abstract available
     
     
109. CHYDERIOTIS S, Sicsic J, Raude J, Bonmarin I, et al
     Optimising HPV vaccination communication to adolescents: A discrete choice experiment.
     Vaccine. 2021 Jun 1. pii: S0264-410X(21)00656.
     PubMed         Abstract available
     
     
110. SHI M, Chen X, Sun Y, Kim HK, et al
     A protein A based Staphylococcus aureus vaccine with improved safety.
     Vaccine. 2021 Jun 1. pii: S0264-410X(21)00667.
     PubMed         Abstract available
     
     
111. JOHM P, Nkoum N, Ceesay A, Mbaye EH, et al
     Factors influencing acceptance of vaccination during pregnancy in The Gambia and Senegal.
     Vaccine. 2021 Jun 1. pii: S0264-410X(21)00663.
     PubMed         Abstract available
     
     
112. YANG T, Liu B, Yue L, Xie T, et al
     Preclinical safety assessment of a combined vaccine against Hepatitis a virus and enterovirus 71.
     Vaccine. 2021 Jun 1. pii: S0264-410X(21)00653.
     PubMed         Abstract available
     
     
113. SHINGAI M, Nomura N, Sekiya T, Ohno M, et al
     Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells.
     Vaccine. 2021 Jun 2. pii: S0264-410X(21)00660.
     PubMed         Abstract available
     
     
114. LASKY T, McMahon AW, Hua W, Forshee R, et al
     Methodologic approaches in studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women: A scoping review.
     Vaccine. 2021 Jun 2. pii: S0264-410X(21)00666.
     PubMed         Abstract available
     
     
115. FERDINANDS JM, Thompson MG, Blanton L, Spencer S, et al
     Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research.
     Vaccine. 2021 Jun 2. pii: S0264-410X(21)00562.
     PubMed         Abstract available
     
     
116. ANDAYI F, Emukule GO, Osoro E, Ndegwa LK, et al
     Knowledge and attitude of Kenyan healthcare workers towards pandemic influenza disease and vaccination: 9 years after the last influenza pandemic.
     Vaccine. 2021 Jun 7. pii: S0264-410X(21)00643.
     PubMed         Abstract available
     
     

     
     Virology

117. OH HS, Yoon JW, Lee S, Kim SO, et al
     A purified inactivated vaccine derived from Vero cell-adapted zika virus elicits protection in mice.
     Virology. 2021;560:124-130.
     PubMed         Abstract available
     
     

     
     Virus Res

118. DOERFLER W
     Viral Vector DNA- and RNA-Based SARS-CoV-2 Vaccines: Possible Integration into the Human Genome Are Adenoviral Genes Expressed in Vector-based Vaccines?
     Virus Res. 2021 Jun 1:198466. doi: 10.1016/j.virusres.2021.198466.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: